Results 261 to 270 of about 315,719 (305)

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin, Hui‐An Lin, Sheng‐Feng Lin   +2 more
wiley   +1 more source

Evaluation of workload among Board-Certified Psychiatric Pharmacists in the United States. [PDF]

Ment Health Clin
Lee KC, Catanzano S, Gross MM, Fahmy M, Gemmellaro JN, Payne GH.   +5 more
europepmc   +1 more source

Time Trends and Predictors of Gout Remission Over 6 Years

Arthritis Care &Research, EarlyView.
Objective This study aims to describe the trends in remission rates over 6 years of follow‐up among people with gout taking urate‐lowering therapy (ULT) and to identify variables that predict remission. Methods A post hoc analysis was conducted using data from the Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout (CARES) trial ...
Adwoa Dansoa Tabi‐Amponsah, Sarah Stewart, Greg Gamble, Lisa K. Stamp, William J. Taylor, Nicola Dalbeth   +5 more
wiley   +1 more source

Establishing a clinical trial site: A primer for aspiring principal investigators. [PDF]

Contemp Clin Trials Commun
Sramek JJ, Carrillo MS, Cutler NR.
europepmc   +1 more source

Proportion of Acceptable Symptom State Nearly Tripled With Improvements in Patient‐Reported Outcomes for All Symptom State Subgroups: A Registry Study of More Than 15,000 Patients With Osteoarthritis in Digital Education and Exercise Therapy

Arthritis Care &Research, EarlyView.
Objective This study investigated trajectories of patient acceptable symptom state (PASS) among participants of digital education and exercise therapy for knee and hip osteoarthritis. Methods A longitudinal observational study among individuals aged at least 40 years who participated in the digital program.
Ali Kiadaliri, L. Stefan Lohmander, Amanda E. Nelson, Leif E. Dahlberg   +3 more
wiley   +1 more source

An international guideline training and certification programme. [PDF]

Bull World Health Organ
Schünemann HJ, Okwen P, Akl E, Chrisp P, Dahm P, Falck-Ytter Y, Florez ID, Follmann M, Harrow E, Jameleddine M, Klugar M, Langendam M, Leng G, Leontiadis G, Lotfi T, Marthe BP, Meerpohl J, Munn Z, Neumann I, Piggott T, Qaseem A, Santesso N, Sultan S, Wiercioch W, Xia J, Nieuwlaat R.   +25 more
europepmc   +1 more source

PENERAPAN HIERARKI CERTIFICATE AUTHORITY DAN PUBLIC KEY INFRASTRUCTURE UNTUK MEMPERKUAT KEAMANAN JARINGAN

Husaini Husaini, Teuku Hafiez Ramadhan, Mahyus Ihsan   +2 more
openalex   +2 more sources

Cancer Risk in Patients With Systemic Sclerosis: A Nationwide Cohort Study in South Korea 2004 to 2021

Arthritis Care &Research, EarlyView.
Objective Systemic sclerosis (SSc) is a rare autoimmune disease characterized by tissue fibrosis, vasculopathy, and immune dysregulation. Our objectives were to quantify the overall and site‐specific cancer risks in patients with SSc compared to the general population, examine temporal trends in cancer incidence following SSc diagnosis, and explore ...
Jihyun Na, Su Jin Choi, Sojeong Park, Minae Park, Doo‐Ho Lim   +4 more
wiley   +1 more source

A Nuclear Medicine Facility in Northeastern Part of India, at Silchar - Genesis and Glimpses on Difficulties in Extending Patient Care. [PDF]

Indian J Nucl Med
Ravichandran R, Mondal T, Kannan R.
europepmc   +1 more source

Treating lupus nephritis patients to lupus low disease activity reduces renal relapse and preserves long‐term kidney function

Arthritis Care &Research, Accepted Article.
Objective Lupus low disease activity state (LLDAS) is a validated treatment target in systemic lupus erythematosus (SLE) but limited studies have explored the role of LLDAS in lupus nephritis (LN). This study aims to investigate the frequency and predictors of LLDAS attainment, and its benefit on LN relapse and renal function preservation in patients ...
Chak Kwan Cheung, Desmond YH Yap, KL Lee, Philip H Li, Iris YK Tang, Chak Sing Lau, Shirley CW Chan   +6 more
wiley   +1 more source